Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
Su Jin ChoiSoo Min AhnJi Seon OhSeokchan HongChang-Keun LeeBin YooYong-Gil KimPublished in: PloS one (2023)
Our study suggests that normalization of serum IgG4 levels during immunosuppressive treatment for IgG4-RD independently predicts relapse-free outcomes. Thus, monitoring serum IgG4 levels might be used as a marker of prognosis.